Most deaths from non-illicit drugs are caused by prescribed opioids and are nearly always due to respiratory arrest during sleep. However, no study has assessed the effect of opioids on vital respiratory drives during sleep. In addition, sleep apnea has been identified as a major risk factor for postoperative morbidity and mortality, while no study investigated how to identify those sleep apnea patients most at risk of opioids. Our proposed studies aim to address these gaps in knowledge.
Systematic Expansion Of The Clinical Evidence Base In Opioid Prescribing For Refractory Dyspnoea At The End Of Life
Funder
National Health and Medical Research Council
Funding Amount
$414,535.00
Summary
Morphine can relieve breathlessness in the palliative setting. But many important questions remain. What is the best dose, should the dose change over time, do different medications provide the same relief, and how common is dyspnoea in the general population? This three part project will extend our knowledge to answer these questions. Population data will provide critical background to plan best care for future palliative patients distressed by breathlessness.